Research On Chickenpox Vaccine Marketing Strategy Of B Pharmaceutical Company

In recent years, with the rapid development of China’s pharmaceutical market, the vaccine industry has entered a new stage of development. The varicella vaccine market in the two types of vaccine as a vaccine, because of the group of children and adolescents in frequent outbreaks of chickenpox has some strong suppression and prevention, suffered more and more social attention. In this context, this paper to B varicella vaccine pharmaceutical company marketing strategies for the study, the literature analysis, case studies and research methods combined SWOT analysis, through B varicella vaccine pharmaceutical company currently marketing analysis of the situation, the current of varicella vaccine marketing macro environment, B pharmaceutical companies varicella vaccine market competition environment, B varicella vaccine pharmaceutical companies in the marketing situation of Zhejiang corresponding analysis carried out, and then by means of the B varicella vaccine pharmaceutical companies marketing SWOT analysis, combined with relevant marketing theory, B varicella vaccine pharmaceutical companies marketing strategies for building and marketing strategy proposed safeguards recommendations.This study consists of six parts, the first part is an introduction to the main research lines and the direction of the article gives a brief introduction; the second part vaccine marketing management theory and literature review, to be elaborated theoretical articles related research needed; The third part is the status quo B chickenpox vaccine pharmaceutical company marketing analysis, the article provides conclusions obtained data corresponding practice and theory; fourth part B chickenpox vaccine pharmaceutical company marketing management, combined with STP theory B Pharmaceuticals varicella vaccine company marketing management for a more detailed discussion; The fifth part B of varicella vaccine pharmaceutical companies marketing strategies and the implementation of safeguards in accordance with the practice of analyzing the results of the third part, combined with the fourth part of the marketing and management to build on the B varicella vaccine pharmaceutical companies marketing 4P marketing strategy build and put forward the corresponding safeguards recommendations. The sixth part is summary and outlook, to be elaborated on the findings, and the lack of research and future research directions in the future.